PMID: 20126851Feb 4, 2010Paper

Gonadotrophic axis dysfunction in men with HIV-infection/aids

Arquivos brasileiros de endocrinologia e metabologia
Clarisse Mourão Melo PonteRenan Magalhães Montenegro

Abstract

Gonadotrophic axis dysfunction is commonly observed in HIV-infected patients. The pathogenesis is multifactorial and related to duration of HIV infection, direct cytopathic effects of viruses, use of drugs, opportunistic infections, malignancies, and malnutrition, among other factors. In men, reduced levels of testosterone is associated with loss of muscle mass and strength, decreased bone mineral density, lipodystrophy, depression, asthenia, fatigue and sexual dysfunction. In HIV-infected patients with hypogonadism, numerous studies have shown the beneficial effects of testosterone replacement on the metabolic profile and distribution of body fat, with increased body mass weight, and promote better quality of life, reduce the bone mass loss and the rates of depression. Thus, this review aimed to present a brief update of epidemiologic data, pathophysiology aspects and treatment strategies for the major abnormalities of male gonadotrophic axis associated with HIV infection and its treatment.

References

Mar 1, 1990·The Journal of Clinical Endocrinology and Metabolism·J A MerenichG S Kidd
Mar 1, 1989·Human Pathology·M E De Paepe, M Waxman
Mar 1, 1988·The American Journal of Medicine·A S DobsB F Polk
Jun 1, 1987·Urology·A B ChabonH Grabstald
Dec 1, 1996·AIDS·J R BergerR Dudley
Oct 30, 1998·The Annals of Pharmacotherapy·K M MelbourneF J Silverblatt
Apr 23, 1999·Journal of Reproductive Immunology·M M ShevchukG Khalife
Apr 24, 1999·International Journal of STD & AIDS·B DonovanD Allen
Feb 22, 2000·JAMA : the Journal of the American Medical Association·S BhasinG Beall
Nov 14, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P RietschelS Grinspoon
Apr 27, 2002·HIV Clinical Trials·Julio CollazosJosé Mayo
Oct 18, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Devon L EvansDavid M Aboulafia
Mar 28, 2003·The Annals of Pharmacotherapy·Patrick G Clay, Amy I Lam
Aug 28, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Odelia B CooperAdrian S Dobs
Jul 2, 2005·Annals of Clinical Biochemistry·Sashi AcharyaRousseau Gama
Nov 17, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert S KleinAdrian S Dobs
Dec 14, 2006·The Journal of Clinical Endocrinology and Metabolism·Shalender BhasinUNKNOWN AIDS Clinical Trials Group Protocol A5079 Study Team
Feb 1, 2007·AIDS Patient Care and STDs·Nancy F Crum-CianfloneMark R Wallace
Jun 5, 2007·Endocrinology and Metabolism Clinics of North America·Rita R KalyaniAdrian S Dobs
Jul 31, 2008·The Journal of Clinical Endocrinology and Metabolism·Susan A HallJohn B McKinlay
Jan 28, 2009·Journal of the International Association of Physicians in AIDS Care : JIAPAC·Julio Collazos, Margarita Esteban

❮ Previous
Next ❯

Citations

Nov 21, 2015·The Open AIDS Journal·Lucília MangonaAntónio Prista
Jul 26, 2019·International Journal of Endocrinology·David D NassoroIssakwisa Habakkuk Mwakyula
Sep 20, 2017·Endocrinology, Diabetes & Metabolism Case Reports·Ana Coelho GomesMário Rui Mascarenhas

❮ Previous
Next ❯

Related Concepts

Related Feeds

HIV/AIDS-Related Malignancies

HIV/AIDS infection increases the risk of non-communicable diseases common in the aged including HIV/AIDS-related malignancies. Discover the latest research in HIV/AIDS-related malignancies.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

© 2021 Meta ULC. All rights reserved